Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Seelos Therapeutics (SEEL)
NASDAQ:SEEL
Seelos Therapeutics (SEEL) Stock Price & Analysis
1,099 Followers
SEEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.37 - $49.80
Previous Close$0.44
Volume496.61K
Average Volume (3M)429.17K
Market Cap
$5.27M
Enterprise Value$20.29M
Total Cash (Recent Filing)$2.58M
Total Debt (Recent Filing)$16.91M
Price to Earnings (P/E)>-0.1
Beta0.72
Next Earnings
Apr 26, 2024EPS Estimate
-$1.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.72
Shares Outstanding13,680,576
10 Day Avg. Volume388,260
30 Day Avg. Volume429,172
Standard Deviation0.32
R-Squared0.10
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.21
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue12.24
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.43
Forecast
1Y Price Target
$4.00Price Target Upside938.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Seelos Therapeutics News
PremiumCompany Announcements
Seelos Therapeutics Issues Common Warrants to Investors
PremiumCompany Announcements
Seelos Therapeutics Strikes $4M Direct Offering Deal
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SEEL FAQ
What was Seelos Therapeutics’s price range in the past 12 months?
Seelos Therapeutics lowest stock price was $0.37 and its highest was $49.80 in the past 12 months.
What is Seelos Therapeutics’s market cap?
Currently, no data Available
When is Seelos Therapeutics’s upcoming earnings report date?
Seelos Therapeutics’s upcoming earnings report date is Apr 26, 2024 which is in 6 days.
How were Seelos Therapeutics’s earnings last quarter?
Seelos Therapeutics released its earnings results on Nov 03, 2023. The company reported -$3.6 earnings per share for the quarter, missing the consensus estimate of -$1.812 by -$1.788.
Is Seelos Therapeutics overvalued?
According to Wall Street analysts Seelos Therapeutics’s price is currently Undervalued.
Does Seelos Therapeutics pay dividends?
Seelos Therapeutics does not currently pay dividends.
What is Seelos Therapeutics’s EPS estimate?
Seelos Therapeutics’s EPS estimate is -$1.48.
How many shares outstanding does Seelos Therapeutics have?
Seelos Therapeutics has 13,680,576 shares outstanding.
What happened to Seelos Therapeutics’s price movement after its last earnings report?
Seelos Therapeutics reported an EPS of -$3.6 in its last earnings report, missing expectations of -$1.812. Following the earnings report the stock price went up 1.121%.
Which hedge fund is a major shareholder of Seelos Therapeutics?
Among the largest hedge funds holding Seelos Therapeutics’s share is Woodline Partners LP. It holds Seelos Therapeutics’s shares valued at N/A.
---
Seelos Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (938.69% Upside)
$4.00 (938.69% Upside)
Blogger Sentiment
Bullish
SEEL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 24.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-98.13%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-76.18%
Trailing 12-Months
Company Description
Seelos Therapeutics
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.
---
SEEL Stock 12 Months Forecast
Average Price Target
$4.00
▲(938.69% Upside)
Technical Analysis
Best Analysts Covering SEEL
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
-47.33%
reiterated a buy rating 7 months ago
Copying Bruce Jackson's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -47.33% per trade.
---